
An experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is showing positive results among older adults in trials, maker Moderna announced Monday. The shot — for now called mRNA-1083 — “has met its primary endpoints, eliciting a higher immune response than the licensed comparator vaccines used in the trial,” Moderna said… read on > read on >